NCT04545944View on ClinicalTrials.gov

Evaluation of Effect of Vonoprazan on Midazolam Pharmacokinetics in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 15, 2020

Primary Completion Date

November 13, 2020

Study Completion Date

November 25, 2020

Conditions
Healthy Volunteers
Interventions
DRUG

Vonoprazan

20 mg tablets administered orally

DRUG

Midazolam

2 mg syrup administered orally

Trial Locations (1)

78744

PPD Development, LP, Austin

Sponsors
All Listed Sponsors
lead

Phathom Pharmaceuticals, Inc.

INDUSTRY